1 October 2018 leonarto

OUR NEXT INVESTMENT IN THE LIFE SCIENCE AREA: BIOTTS SA

BIOTTS SA – Wroclaw biotechnology startup – creates proprietary medicinal preparations dedicated among others to areas of medicine such as oncology, immunology or neurology.
As part of the Leonarto Alfa investment, the Company will develop innovative carriers of therapeutic substances with the possibility of application in transdermal therapeutic systems, patches, ointments, gels. The carriers contain mixtures of substances compatible with human skin coatings, non-sensitizing, non-irritant, and most importantly, increasing the absorption of medicinal substances.
We keep our fingers crossed for the team headed by the founders of the company – Dr. Jan Meler and Dr. Paweł Biernat.

Leonarto Alfa investment is co-financed by the European Union from the European Regional Development Fund under the Operational Program Smart Development, Sub-measure 1.3.1. Support for research and development projects in the preseed phase by proof of concept funds – BRIdge Alfa.

Contact us